Vor Biopharma Share Price Today
(NASDAQ: VOR)

Name: Vor Biopharma Share Price Today (NASDAQ: VOR) - Vor Biopharma Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vor Biopharma share price is $0.73 & ₹62.29 as on 25 Apr 2025, 2.30 'hrs' IST

$0.73

▲

-0.03

(-4.19%)

Market is closed - opens 7 PM, 25 Apr 2025

View live Vor Biopharma share price in Dollar and Rupees. Guide to invest in Vor Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vor Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Vor Biopharma share price movements

Today's Low: $0.72
Today's High: $0.78
$0.73
1.37%
Downside
Day's Volatility :7.81%
Upside
6.53%
52 Weeks Low: $0.49
52 Weeks High: $1.87
$0.73
32.88%
Downside
52 Weeks Volatility :73.8%
Upside
60.96%

Vor Biopharma (VOR) Returns

Period	Vor Biopharma Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-47.99%	-6.0%	0.0%
6 Months	4.84%	-9.2%	0.0%
1 Year	-55.18%	-3.7%	0.0%
3 Years	-86.39%	1.5%	-8.8%

Vor Biopharma (VOR) Key Statistics

in dollars & INR

Previous Close	$0.7591
Open	$0.781
Today's High	$0.781
Today's Low	$0.72
Market Capitalization	$87.6M
Today's Volume	$330.4K
52 Week High	$1.87
52 Week Low	$0.49
Revenue TTM	$0.0
EBITDA	$-117.7M
Earnings Per Share (EPS)	$-1.7
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-94.52%

How to invest in Vor Biopharma Stock (VOR) from India?

It is very easy for Indian residents to invest directly in Vor Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vor Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vor Biopharma or VOR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vor Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vor Biopharma shares which would translate to 1.169 fractional shares of Vor Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vor Biopharma, in just a few clicks!

Returns in Vor Biopharma (VOR) for Indian investors in Rupees

The Vor Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vor Biopharma investment value today

Current value as on today

₹45,338

Returns

₹54,662

(-54.66%)

Returns from Vor Biopharma Stock

₹57,059 (-57.06%)

Dollar Returns

₹2,397 (+2.4%)

Indian investors sentiment towards Vor Biopharma (VOR)

-18%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Vor Biopharma Stock from India on INDmoney has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vor Biopharma

RA Capital Management, LLC
31.75%
FMR Inc
5.14%
5AM Venture Management, LLC
5.10%
Vanguard Group Inc
1.56%
COWEN AND COMPANY, LLC
0.98%
Johnson & Johnson
0.86%

Analyst Recommendation on Vor Biopharma

Rating

Trend

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Vor Biopharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Vor Biopharma Stock (VOR)

What analysts predicted

Upside of 1289.44%

Target:

$10.14

Current:

$0.73

Insights on Vor Biopharma Stock (Ticker Symbol: VOR)

Price Movement
In the last 7 days, VOR stock has moved up by 17.2%
VOR vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 73.9% return, outperforming this stock by 130.1%
VOR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 53.1% return, outperforming this stock by 139.5%

Vor Biopharma Technicals Summary

Sell

Neutral

Buy

Vor Biopharma is currently in a neutral trading position according to technical analysis indicators.

Vor Biopharma (VOR) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vor Biopharma Inc	-10.07%	4.84%	-55.18%	-86.39%	-96.29%
Regeneron Pharmaceuticals, Inc.	-8.15%	-36.99%	-33.99%	-12.87%	7.38%
Beone Medicines Ltd	-0.1%	17.79%	68.73%	64.3%	51.92%
Vertex Pharmaceuticals Incorporated	-1.59%	3.06%	23.79%	83.91%	83.35%
Alnylam Pharmaceuticals, Inc.	-9.98%	-14.92%	68.63%	56.35%	69.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vor Biopharma Inc	NA	NA	NA	-0.9	-0.95	-0.44	NA	0.78
Regeneron Pharmaceuticals, Inc.	15.27	15.27	0.93	40.58	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vor Biopharma Inc	Buy	$87.6M	-96.29%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$62.9B	7.38%	15.27	31.07%
Beone Medicines Ltd	NA	$28.7B	51.92%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$126.1B	83.35%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.6B	69.83%	NA	-12.37%

About Vor Biopharma

Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Organization	Vor Biopharma
Employees	159
CEO	Dr. Robert Ang M.B.A., M.D., MBBS
Industry	Services

Management People of Vor Biopharma

Name	Title
Dr. Robert Ang M.B.A., M.D., MBBS	President, CEO & Director
Dr. Tirtha Chakraborty Ph.D.	Chief Scientific Officer & Head of Technical Operations
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.	Scientific Founder & Chairman of Scientific Advisory Board
Dr. Han Choi M.D.	Chief Financial Officer
Ms. Amy Quinlan	Interim Principal Accounting Officer
Ms. Tania Philipp	Chief People Officer
Mr. David Phillips M.B.A.	Senior VP & Head of Quality

Important FAQs about investing in VOR Stock from India :

What is Vor Biopharma share price today?

Vor Biopharma share price today stands at $0.73, Open: $0.78 ; Previous Close: $0.76 ; High: $0.78 ; Low: $0.72 ; 52 Week High: $1.87 ; 52 Week Low: $0.49.

The stock opens at $0.78, after a previous close of $0.76. The stock reached a daily high of $0.78 and a low of $0.72, with a 52-week high of $1.87 and a 52-week low of $0.49.

Can Indians buy Vor Biopharma shares?

Yes, Indians can invest in the Vor Biopharma (VOR) from India.

With INDmoney, you can buy Vor Biopharma at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vor Biopharma at zero transaction cost.

How can I buy Vor Biopharma shares from India?

It is very easy to buy Vor Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vor Biopharma (VOR) be purchased?

Yes, you can buy fractional shares of Vor Biopharma with INDmoney app.

What are the documents required to start investing in Vor Biopharma stocks?

To start investing in Vor Biopharma, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.